Metabolism of vitamin D3 by cytochromes P450 - PubMed (original) (raw)
Review
doi: 10.2741/1514. Print 2005 Jan 1.
Affiliations
- PMID: 15574355
- DOI: 10.2741/1514
Review
Metabolism of vitamin D3 by cytochromes P450
Toshiyuki Sakaki et al. Front Biosci. 2005.
Abstract
The vitamin D3 25-hydroxylase (CYP27A1), 25-hydroxyvitamin D3 1alpha-hydroxylase (CYP27B1) and 1alpha,25-dihydroxyvitamin D3 24-hydroxylase (CYP24A1) are members of the cytochrome P450 superfamily, and key enzymes of vitamin D3 metabolism. Using the heterologous expression in E. coli, enzymatic properties of the P450s were recently investigated in detail. Upon analyses of the metabolites of vitamin D3 by the reconstituted system, CYP27A1 surprisingly produced at least seven forms of minor metabolites including 1alpha,25(OH)2D3 in addition to the major metabolite 25(OH)D3. These results indicated that human CYP27A1 catalyzes multiple reactions involved in the vitamin D3 metabolism. In contrast, CYP27B1 only catalyzes the hydroxylation at C-1alpha position of 25(OH)D3 and 24R,25(OH)2D3. Enzymatic studies on substrate specificity of CYP27B1 suggest that the 1alpha-hydroxylase activity of CYP27B1 requires the presence of 25-hydroxyl group of vitamin D3 and is enhanced by 24-hydroxyl group while the presence of 23-hydroxyl group greatly reduced the activity. Eight types of missense mutations in the CYP27B1 gene found in vitamin D-dependent rickets type I (VDDR-I) patients completely abolished the 1alpha-hydroxylase activity. A three-dimensional model of CYP27B1 structure simulated on the basis of the crystal structure of rabbit CYP2C5 supports the experimental data from mutagenesis study of CYP27B1 that the mutated amino acid residues may be involved in protein folding, heme-propionate binding or activation of molecular oxygen. CYP24A1 expressed in E. coli showed a remarkable metabolic processes of 25(OH)D3 and 1alpha,25(OH)2D3. Rat CYP24A1 catalyzed six sequential monooxygenation reactions that convert 1alpha,25(OH)2D3 into calcitroic acid, a known final metabolite of C-24 oxidation pathway. In addition to the C-24 oxidation pathway, human CYP24A1 catalyzed also C-23 oxidation pathway to produce 1alpha,25(OH)2D3-26,23-lactone. Surprisingly, more than 70 % of the vitamin D metabolites observed in a living body were found to be the products formed by the activities of CYP27A1, CYP27B1 and CYP24A1. The species-based difference was also observed in the metabolism of vitamin D analogs by CYP24A1, suggesting that the recombinant system for human CYP24A1 may be of great use for the prediction of the metabolism of vitamin D analogs in humans.
Similar articles
- [Recent studies on vitamin D metabolizing enzymes].
Sakaki T. Sakaki T. Clin Calcium. 2006 Jul;16(7):1129-35. Clin Calcium. 2006. PMID: 16816472 Review. Japanese. - Structure-function analysis of CYP27B1 and CYP27A1. Studies on mutants from patients with vitamin D-dependent rickets type I (VDDR-I) and cerebrotendinous xanthomatosis (CTX).
Sawada N, Sakaki T, Kitanaka S, Kato S, Inouye K. Sawada N, et al. Eur J Biochem. 2001 Dec;268(24):6607-15. doi: 10.1046/j.0014-2956.2001.02615.x. Eur J Biochem. 2001. PMID: 11737215 - Enzymatic studies on the key enzymes of vitamin D metabolism; 1 alpha-hydroxylase (CYP27B1) and 24-hydroxylase (CYP24).
Inouye K, Sakaki T. Inouye K, et al. Biotechnol Annu Rev. 2001;7:179-94. doi: 10.1016/s1387-2656(01)07037-5. Biotechnol Annu Rev. 2001. PMID: 11686044 Review. - Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D₃ that resists the catalytic activity of both CYP27B1 and CYP24A1.
Rhieu SY, Annalora AJ, LaPorta E, Welsh J, Itoh T, Yamamoto K, Sakaki T, Chen TC, Uskokovic MR, Reddy GS. Rhieu SY, et al. J Cell Biochem. 2014 Aug;115(8):1392-402. doi: 10.1002/jcb.24789. J Cell Biochem. 2014. PMID: 24535953 - Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S, Byford V, Arabian A, Sakai Y, Demay MB, St-Arnaud R, Jones G. Masuda S, et al. Endocrinology. 2005 Feb;146(2):825-34. doi: 10.1210/en.2004-1116. Epub 2004 Oct 21. Endocrinology. 2005. PMID: 15498883
Cited by
- Vitamin D beyond the blood: Tissue distribution of vitamin D metabolites after supplementation.
Shadid ILC, Guchelaar HJ, Weiss ST, Mirzakhani H. Shadid ILC, et al. Life Sci. 2024 Oct 15;355:122942. doi: 10.1016/j.lfs.2024.122942. Epub 2024 Aug 10. Life Sci. 2024. PMID: 39134205 Review. - 4-Hydroxy-1α,25-Dihydroxyvitamin D3: Synthesis and Structure-Function Study.
Peluso-Iltis C, Pierrat N, Rovito D, Osz J, Sawada D, Kittaka A, Laverny G, Rochel N. Peluso-Iltis C, et al. Biomolecules. 2024 May 3;14(5):551. doi: 10.3390/biom14050551. Biomolecules. 2024. PMID: 38785958 Free PMC article. - CYP27B1 Enzyme in Psoriasis: A Preliminary Study of Immunohistochemical Observations.
Paliu IA, Olinca MV, Ianosi SL, Georgescu CV, Turcu-Stiolica A, Diaconu M, Dumitrescu CI, Tica AA. Paliu IA, et al. Life (Basel). 2023 Dec 21;14(1):15. doi: 10.3390/life14010015. Life (Basel). 2023. PMID: 38276264 Free PMC article. - Efficient Stereo-Selective Fluorination on Vitamin D3 Side-Chain Using Electrophilic Fluorination.
Kawagoe F, Mototani S, Kittaka A. Kawagoe F, et al. Biomolecules. 2023 Dec 26;14(1):37. doi: 10.3390/biom14010037. Biomolecules. 2023. PMID: 38254637 Free PMC article. - Methotrexate Chemotherapy Causes Growth Impairments, Vitamin D Deficiency, Bone Loss, and Altered Intestinal Metabolism-Effects of Calcitriol Supplementation.
Su YW, Lee AMC, Xu X, Hua B, Tapp H, Wen XS, Xian CJ. Su YW, et al. Cancers (Basel). 2023 Sep 1;15(17):4367. doi: 10.3390/cancers15174367. Cancers (Basel). 2023. PMID: 37686643 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases